medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2004, Number 1

Next >>

Rev Mex Oftalmol 2004; 78 (1)

Incidencia de retinopatía del prematuro en el hospital Dr. Manuel Gea González

González-Urquidi O, Fuente-Torres MA

Language: Spanish
References: 14
Page: 1-4
PDF size: 192.76 Kb.


ABSTRACT

Purpose: To analyze the incidence of retinopathy of prematurity in the "Hospital Gea González".
Methods: A prospective, observational and descriptive study was realized including premature patients with birth weight 1500 to 2000 g and supplemental oxygen therapy.
Evaluation was performed on the 4th and 6th week of chronological age.
Results: 33 male (45.20%) and 40 female patients (54.80%) were included in the study. Gestation age average was 32.41 weeks and weight average 1320 g.
The incidence of retinopathy of prematurity was 23%.
Conclusion: The incidence in this study is lower than that reported worldwide.


REFERENCES

  1. American Academy of Pediatrics. Clinical considerations in the use of oxygen. En: Freeman RK, Polan RL, Haunt JC, Merenstein GB (eds.) Guidelines for perinatal care. Chicago, American Academy of Pediatrics, 1992; 197-203.

  2. Pierce E, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxigen in a model retinopathy of prematurity. Arch Ophthalmology 1996; 114:1219-1228.

  3. Stop-ROP. Results suggest selective use of supplemental oxygen for Prethreshold. Arch Ophtahlmol 2000; 118.

  4. Kinsey VE, Jacobus JT, Hemphill F. Retrolental fibroplasia: cooperative study of retrolental fibroplasia and the use of Oxygen. Arch Ophthalmol 1956; 56:481-457.

  5. Multicenter Trial of Cryotherapy for retinopathy of prematurity (CRYO-ROP). Cooperative group, manual of procedures. Springfield, National Technical Information Service, US Dept of Commerce, 1985. Publication pb88-163530.

  6. The Commitee for the Classification of retinopathy of prematurity. An international classification for the retinopaty of prematurity. Arch Ophthalmol 1984;102:1130-1134.

  7. Mitchell H, DeJonge P, Ferrone J. Diode laser ablation for Threshold Retinopathy of prematurity. Short term Structural Outcome. Arch Ophthalmol 2000; 118:365 367.

  8. Goggin M, O’Keefe M. Diode laser for retinophaty of prematurity, early outcome. Brit J Ophthal 1993, 559-562.

  9. Capone A, Diaz-Rhoena R, Sternberg PM, Lamberth HM, Lopez PF. Diode laser photocoagulation for zone I threshold retinopaty of prematurity. Am J Ophthal 1993; 116:444-450.

  10. Ling CS, Fleck BW, Wright E, Anderson C, Llaing I: Diode laser treatament for retinopathy of prematurity, structural and functional outcomne. Brit J Ophthal 1995; 79:637-641.

  11. Hunter DG, Repka MX. Diode laser photogoluation for threshold retinopaty prematuruty, and randomized study. Ophthalmology 1993; 100:238-244.

  12. Christiansen SP, Bradford JD, Cataracts in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. J Ped Ophthal Strab 1997; 34:123-124.

  13. Cooperative group. Multicenter trial of cryotherapy for prematurity, prelimiany results. Cryotherapy for retinopathy of prematurity. Arch Ophtahlmol 1988; 106:471-479.

  14. Cooperative group. Multicenter trial of cryotherapy for retinopathy of prematurity. Cryotherapy for retinopathy of prematurity, 3 1/2 years outcome-structure and function. Arch Ophtalmol 1993;111:339-344.




2020     |     www.medigraphic.com